
10/05/2022
Why the most popular Female Breast Cancer DNA tests are terrible
Let’s start with how your DNA is gathered, processed, and analyzed.
It takes specialized equipment and people to extract DNA and get it analyzed.
To save costs, some brilliant people invented ‘Microarray Panels.’ These chemically programmed chips are designed to interact with genetic variants. Each variant must be programmed into the chip.
They are very accurate for variants for which they are designed, but have severe limitations. If the variant you want isn’t programmed into the chip, you can never know.
Microarrays are used by the most popular tests because they are very, very cheap to produce, and give results quickly. What information they give can be accurate, but what about what they do not have? That could mean life or death – literally.
Because of this we have coined the phrase ‘Genutainment.’ It is really genetic entertainment. Go read many of the reports on many ’health’ related tests. They have more disclaimers than they have actual results. Instead, we choose to analyze every single gene and genetic variant – and we store them all forever.
Look at Female Breast Cancer. Everyone has heard of the famous BRCA1, and BRCA2 genes that Myriad Genetics tried (and failed) to patent. That didn’t keep them from capitalizing on these and offering ‘solid’ genetic tests around these genes. Since they are well-known, you have a fairly good chance of insurance paying for it. Millions and millions of dollars are spent on their test, also on 23andMe’s, every year. We feel the data is woefully lacking when it comes to your health.
Even until March of 2020, Myriad Genetic’s Breast Cancer test only covered BRCA1/BRCA2 genes, and the cost? $2,436.00. What about the other genes implicated in Breast Cancer?
That is from their form that was valid until March of 2022.
Fast forward to 2022:
Directly from Myriad’s website:
Integrated BRACAnalysis®: Analysis of BRCA1, and BRCA2 for susceptibility to Hereditary Breast and Ovarian Cancer syndrome.
The total number of genes Myriad covers for breast cancer is now 12. A vast improvement.
Now imagine: True DNA Story analyzes 14 genes and over 980 genetic variants – and always has. We store data on over 700 genes for Breast Cancer.
We didn’t want every woman to think they had Breast Cancer so we pared those 700 genes to the critical 14 according to the NIH, NCBI, and the Royal Academy of Science. For Female Breast Cancer, True DNA Story analyzes, and reports on every gene allowed by the FDA against fully curated data. We constantly research all the major global databases to ensure your reports up-to-date. The neat part is that when science curates more data, we already have the results ready to report on. We re-run your reports free for life, and send you an email to let you know there might be changes.
Welcome to the True DNA Story family.
Know your Story, change your Life.